BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu C, Hua Q, Zheng L. Generation of Myeloid Cells in Cancer: The Spleen Matters. Front Immunol 2020;11:1126. [PMID: 32582203 DOI: 10.3389/fimmu.2020.01126] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Yu J, Choi S, Park A, Do J, Nam D, Kim Y, Noh J, Lee KY, Maeng CH, Park KS. Bone Marrow Homeostasis Is Impaired via JAK/STAT and Glucocorticoid Signaling in Cancer Cachexia Model. Cancers (Basel) 2021;13:1059. [PMID: 33801569 DOI: 10.3390/cancers13051059] [Reference Citation Analysis]
2 Monteran L, Ershaid N, Sabah I, Fahoum I, Zait Y, Shani O, Cohen N, Eldar-Boock A, Satchi-Fainaro R, Erez N. Bone metastasis is associated with acquisition of mesenchymal phenotype and immune suppression in a model of spontaneous breast cancer metastasis. Sci Rep 2020;10:13838. [PMID: 32796899 DOI: 10.1038/s41598-020-70788-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
3 Grzywa TM, Justyniarska M, Nowis D, Golab J. Tumor Immune Evasion Induced by Dysregulation of Erythroid Progenitor Cells Development. Cancers (Basel) 2021;13:870. [PMID: 33669537 DOI: 10.3390/cancers13040870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Al-Hity G, Yang F, Campillo-Funollet E, Greenstein AE, Hunt H, Mampay M, Intabli H, Falcinelli M, Madzvamuse A, Venkataraman C, Flint MS. An integrated framework for quantifying immune-tumour interactions in a 3D co-culture model. Commun Biol 2021;4:781. [PMID: 34168276 DOI: 10.1038/s42003-021-02296-7] [Reference Citation Analysis]
5 Vito A, El-Sayes N, Salem O, Wan Y, Mossman KL. Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer. Cancers (Basel) 2021;13:5590. [PMID: 34771752 DOI: 10.3390/cancers13215590] [Reference Citation Analysis]
6 Wildes TJ, DiVita Dean B, Flores CT. Myelopoiesis during Solid Cancers and Strategies for Immunotherapy. Cells 2021;10:968. [PMID: 33919157 DOI: 10.3390/cells10050968] [Reference Citation Analysis]
7 Kimm MA, Klenk C, Alunni-Fabbroni M, Kästle S, Stechele M, Ricke J, Eisenblätter M, Wildgruber M. Tumor-Associated Macrophages-Implications for Molecular Oncology and Imaging. Biomedicines 2021;9:374. [PMID: 33918295 DOI: 10.3390/biomedicines9040374] [Reference Citation Analysis]
8 Luo S, Lin H, Zhu L, Chen HT, Yang S, Li J, Liu M, Zheng L, Wu C. Optimized Intracellular Staining Reveals Heterogeneous Cytokine Production Ability of Murine and Human Hematopoietic Stem and Progenitor Cells. Front Immunol 2021;12:654094. [PMID: 33936078 DOI: 10.3389/fimmu.2021.654094] [Reference Citation Analysis]
9 Kim Y, Choi C, Park JH, Ahn W, Shin S, Kim S, Noh JM. Immunomodulatory effect of splenectomy in lung cancer mouse xenograft models receiving radiation therapy. Radiat Oncol J 2022;40:53-65. [DOI: 10.3857/roj.2021.00885] [Reference Citation Analysis]
10 Pingili AK, Chaib M, Sipe LM, Miller EJ, Teng B, Sharma R, Yarbro JR, Asemota S, Al Abdallah Q, Mims TS, Marion TN, Daria D, Sekhri R, Hamilton AM, Troester MA, Jo H, Choi HY, Hayes DN, Cook KL, Narayanan R, Pierre JF, Makowski L. Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancer. Cell Rep 2021;35:109285. [PMID: 34161764 DOI: 10.1016/j.celrep.2021.109285] [Reference Citation Analysis]
11 Trofimova O, Korotkaja K, Skrastina D, Jansons J, Spunde K, Isaguliants M, Zajakina A. Alphavirus-Driven Interferon Gamma (IFNg) Expression Inhibits Tumor Growth in Orthotopic 4T1 Breast Cancer Model. Vaccines (Basel) 2021;9:1247. [PMID: 34835178 DOI: 10.3390/vaccines9111247] [Reference Citation Analysis]
12 Tao H, Liu M, Wang Y, Luo S, Xu Y, Ye B, Zheng L, Meng K, Li L. Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation. Front Immunol 2021;12:609295. [PMID: 33717093 DOI: 10.3389/fimmu.2021.609295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Liu M, Wu C, Luo S, Hua Q, Chen HT, Weng Y, Xu J, Lin H, Wang L, Li J, Zhu L, Guo Z, Zhuang SM, Kang T, Zheng L. PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen. J Exp Med 2022;219:e20211498. [PMID: 35266960 DOI: 10.1084/jem.20211498] [Reference Citation Analysis]
14 Reijmen E, De Mey S, De Mey W, Gevaert T, De Ridder K, Locy H, Martens S, De Blay E, Bouwens L, Debie P, Breckpot K, De Grève J, De Ridder M, Goyvaerts C. Fractionated Radiation Severely Reduces the Number of CD8+ T Cells and Mature Antigen Presenting Cells Within Lung Tumors. Int J Radiat Oncol Biol Phys 2021;111:272-83. [PMID: 33865948 DOI: 10.1016/j.ijrobp.2021.04.009] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Liu J, Xu J, Zhang T, Xu K, Bao P, Zhang Z, Xue K, He R, Ma L, Wang Y. Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy. Front Immunol 2022;13:791158. [DOI: 10.3389/fimmu.2022.791158] [Reference Citation Analysis]
16 Lewis R, Habringer S, Kircher M, Hefter M, Peuker CA, Werner R, Ademaj-Kospiri V, Gäble A, Weber W, Wester HJ, Buck A, Herhaus P, Lapa C, Keller U. Investigation of spleen CXCR4 expression by [68Ga]Pentixafor PET in a cohort of 145 solid cancer patients. EJNMMI Res 2021;11:77. [PMID: 34417915 DOI: 10.1186/s13550-021-00822-6] [Reference Citation Analysis]
17 Mojsilovic S, Mojsilovic SS, Bjelica S, Santibanez JF. Transforming growth factor-beta1 and myeloid-derived suppressor cells: A cancerous partnership. Dev Dyn 2021. [PMID: 33797140 DOI: 10.1002/dvdy.339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Li P, Wu L, Li Z, Li J, Ye W, Shi Z, Xu Z, Zhu C, Ye H, Liu Z, Liang C. Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection. Front Oncol 2021;11:716849. [PMID: 34485152 DOI: 10.3389/fonc.2021.716849] [Reference Citation Analysis]